⌘K
Ampersand Biomedicines
Healthcare & Life Sciences
Recent Finacing
Series B
Recent Raise
$65M
Ampersand Biomedicines develops smart medicines using their AND™ platform to precisely target specific areas in the body for improved therapeutic effects in immuno-inflammation and immuno-oncology.
Focus Areas
Immuno-inflammation
Immuno-oncology
Smart medicines
Targeted therapy
AND™ platform
Investors
